378 related articles for article (PubMed ID: 34589423)
1. The Role of Non-Coding RNAs in Breast Cancer Drug Resistance.
Tian JH; Liu SH; Yu CY; Wu LG; Wang LB
Front Oncol; 2021; 11():702082. PubMed ID: 34589423
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer.
Yi Y; Wu M; Zeng H; Hu W; Zhao C; Xiong M; Lv W; Deng P; Zhang Q; Wu Y
Front Oncol; 2021; 11():738945. PubMed ID: 34707990
[TBL] [Abstract][Full Text] [Related]
3. Circular RNAs: Their Role in the Pathogenesis and Orchestration of Breast Cancer.
He X; Xu T; Hu W; Tan Y; Wang D; Wang Y; Zhao C; Yi Y; Xiong M; Lv W; Wu M; Li X; Wu Y; Zhang Q
Front Cell Dev Biol; 2021; 9():647736. PubMed ID: 33777954
[TBL] [Abstract][Full Text] [Related]
4. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
Wei L; Sun J; Zhang N; Shen Y; Wang T; Li Z; Yang M
Front Cell Dev Biol; 2021; 9():764313. PubMed ID: 34881242
[TBL] [Abstract][Full Text] [Related]
5. Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer.
Treeck O; Haerteis S; Ortmann O
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980520
[TBL] [Abstract][Full Text] [Related]
6. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms.
Rezaee M; Mohammadi F; Keshavarzmotamed A; Yahyazadeh S; Vakili O; Milasi YE; Veisi V; Dehmordi RM; Asadi S; Ghorbanhosseini SS; Rostami M; Alimohammadi M; Azadi A; Moussavi N; Asemi Z; Aminianfar A; Mirzaei H; Mafi A
Front Pharmacol; 2023; 14():1152672. PubMed ID: 37153758
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.
Lan H; Yuan J; Zeng D; Liu C; Guo X; Yong J; Zeng X; Xiao S
Front Genet; 2021; 12():693259. PubMed ID: 34512721
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism.
Hashem M; Mohandesi Khosroshahi E; Aliahmady M; Ghanei M; Soofi Rezaie Y; Alsadat Jafari Y; Rezaei F; Khodaparast Eskadehi R; Kia Kojoori K; Jamshidian F; Nabavi N; Rashidi M; Hasani Sadi F; Taheriazam A; Entezari M
Noncoding RNA Res; 2024 Jun; 9(2):560-582. PubMed ID: 38515791
[TBL] [Abstract][Full Text] [Related]
9. Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer.
Guo XQ; Hua YM
Neoplasma; 2022 Sep; 69(5):1019-1028. PubMed ID: 35900318
[TBL] [Abstract][Full Text] [Related]
10. Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis.
Tabatabaeian H; Peiling Yang S; Tay Y
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158279
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNAs in Drug Resistance of Breast Cancer.
Du T; Shi Y; Xu S; Wan X; Sun H; Liu B
Onco Targets Ther; 2020; 13():7075-7087. PubMed ID: 32764993
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA.
Ye S; Chen S; Yang X; Lei X
Discov Oncol; 2024 May; 15(1):138. PubMed ID: 38691224
[TBL] [Abstract][Full Text] [Related]
13. Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches.
Jesenko T; Brezar SK; Cemazar M; Biasin A; Tierno D; Scaggiante B; Grassi M; Grassi C; Dapas B; Truong NH; Abrami M; Zanconati F; Bonazza D; Rizzolio F; Parisi S; Pastorin G; Grassi G
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111734
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs: New layer of complexity evading breast cancer heterogeneity.
Dawoud A; Ihab Zakaria Z; Hisham Rashwan H; Braoudaki M; Youness RA
Noncoding RNA Res; 2023 Mar; 8(1):60-74. PubMed ID: 36380816
[TBL] [Abstract][Full Text] [Related]
15. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications.
Chen D; Ping S; Xu Y; Wang M; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
Front Cell Dev Biol; 2021; 9():732036. PubMed ID: 34805143
[TBL] [Abstract][Full Text] [Related]
16. Noncoding RNAs in gastric cancer: implications for drug resistance.
Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Long Non-coding and Circular RNAs in Human Papillomavirus-Mediated Cervical Cancer.
Wang H; Zhao Y; Chen M; Cui J
Front Microbiol; 2017; 8():1720. PubMed ID: 28970820
[TBL] [Abstract][Full Text] [Related]
18. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.
Abdollahzadeh R; Daraei A; Mansoori Y; Sepahvand M; Amoli MM; Tavakkoly-Bazzaz J
J Cell Physiol; 2019 Jul; 234(7):10080-10100. PubMed ID: 30537129
[TBL] [Abstract][Full Text] [Related]
19. A transcriptomic profile of topping responsive non-coding RNAs in tobacco roots (Nicotiana tabacum).
Chen X; Sun S; Liu F; Shen E; Liu L; Ye C; Xiao B; Timko MP; Zhu QH; Fan L; Cao P
BMC Genomics; 2019 Nov; 20(1):856. PubMed ID: 31726968
[TBL] [Abstract][Full Text] [Related]
20. Landscape of NcRNAs involved in drug resistance of breast cancer.
Kang Y
Clin Transl Oncol; 2023 Jul; 25(7):1869-1892. PubMed ID: 37067729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
